Interestingly, when a dual orexin receptor antagonist, almorexant, was infused intracerebroventricularly (icv) during in vivo microdialysis for an ISF Aβexperiment, Kang et al discovered that the ISF Aβ levels were suppressed and the natural diurnal variation of Aβ was also abolished.